2020 annual financial data
Emergent BioSolutions Inc. Common Stock 2020 Operating margin
Emergent BioSolutions Inc. Common Stock 2020 operating margin with verified rep…
Direct answer
Operating margin was 27.8%.
Operating income was 438,500,000 USD and net income was 305,800,000 USD.
Operating cash flow was 536,900,000 USD.
Get free Emergent BioSolutions Inc. Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,577,300,000 USD
- Operating income
- 438,500,000 USD
- Net income
- 305,800,000 USD
- Operating cash flow
- 536,900,000 USD
Explore related company data
View all 2020 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Emergent BioSolutions Inc. Common Stock financial years